Source 1review2025MED
Toolkit/gene editing technology
gene editing technology
Also known as: gene editing
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Gene editing technology is an engineering method used for animal model construction. The supplied evidence specifically states that it has been widely applied to nonhuman primate model generation in recent years.
Usefulness & Problems
Why this is useful
This technology is useful for generating genetically modified nonhuman primate models for biomedical research. The supplied review frames it as an important approach for animal model construction, while also noting that practical application is shaped by limiting factors.
Source:
In terms of animal model construction, gene editing technology has been widely applied to this area in recent years.
Problem solved
It helps address the need to construct nonhuman primate animal models with defined genetic modifications. The evidence does not specify particular editing platforms, target genes, or disease areas.
Source:
In terms of animal model construction, gene editing technology has been widely applied to this area in recent years.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete method used to build, optimize, or evolve an engineered system.
Mechanisms
genome editingTechniques
Directed EvolutionTarget processes
editingInput: Chemical
Implementation Constraints
The supplied evidence supports use in nonhuman primate animal model construction but does not provide operational details such as nuclease class, delivery modality, construct architecture, or required reagents. No specific implementation parameters can be extracted from the provided text.
The review explicitly states that applications of genetically modified nonhuman primate models face limiting factors. However, the provided evidence excerpt does not enumerate those factors or define specific technical constraints, efficiencies, or failure modes.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Source 2review2022Frontiers in Cell and Developmental Biology
Source 3primary paper2025MED
Ranked Claims
FDA approval of voretigene neparvovec validated the clinical viability of ocular gene therapy.
Dual AAV vectors, lipid nanoparticles, and novel biomaterials have enhanced the efficiency and specificity of gene delivery to the retina.
Future ocular gene therapy development is expected to include prime editing, miRNA-based regulation, and combinatorial approaches with stem cell transplantation or neuroprotective agents.
Gene editing technology and optogenetic manipulation face challenges in direct application to human conditions.
Gene augmentation, gene editing, RNA-based therapies, and optogenetics have shown significant progress in preclinical studies and clinical trials across posterior segment eye disease subtypes.
Gene editing technology is an emerging promising tool for restoring excitatory/inhibitory balance and may help ameliorate motor deficits in aging.
Gene editing technology has been widely applied to nonhuman primate animal model construction in recent years.
In terms of animal model construction, gene editing technology has been widely applied to this area in recent years.
Gene editing technology has been widely applied to nonhuman primate animal model construction in recent years.
In terms of animal model construction, gene editing technology has been widely applied to this area in recent years.
Gene editing technology has been widely applied to nonhuman primate animal model construction in recent years.
In terms of animal model construction, gene editing technology has been widely applied to this area in recent years.
Gene editing technology has been widely applied to nonhuman primate animal model construction in recent years.
In terms of animal model construction, gene editing technology has been widely applied to this area in recent years.
Gene editing technology has been widely applied to nonhuman primate animal model construction in recent years.
In terms of animal model construction, gene editing technology has been widely applied to this area in recent years.
Gene editing technology has been widely applied to nonhuman primate animal model construction in recent years.
In terms of animal model construction, gene editing technology has been widely applied to this area in recent years.
Gene editing technology has been widely applied to nonhuman primate animal model construction in recent years.
In terms of animal model construction, gene editing technology has been widely applied to this area in recent years.
Applications of genetically modified nonhuman primate models face limiting factors, and the review discusses possible solutions, improvements, prospects, and challenges.
In addition, we discuss the limiting factors in the applications of genetically modified NHP models as well as the possible solutions and improvements. Furthermore, we highlight the prospects and challenges of the gene-edited NHP models.
Applications of genetically modified nonhuman primate models face limiting factors, and the review discusses possible solutions, improvements, prospects, and challenges.
In addition, we discuss the limiting factors in the applications of genetically modified NHP models as well as the possible solutions and improvements. Furthermore, we highlight the prospects and challenges of the gene-edited NHP models.
Applications of genetically modified nonhuman primate models face limiting factors, and the review discusses possible solutions, improvements, prospects, and challenges.
In addition, we discuss the limiting factors in the applications of genetically modified NHP models as well as the possible solutions and improvements. Furthermore, we highlight the prospects and challenges of the gene-edited NHP models.
Applications of genetically modified nonhuman primate models face limiting factors, and the review discusses possible solutions, improvements, prospects, and challenges.
In addition, we discuss the limiting factors in the applications of genetically modified NHP models as well as the possible solutions and improvements. Furthermore, we highlight the prospects and challenges of the gene-edited NHP models.
Applications of genetically modified nonhuman primate models face limiting factors, and the review discusses possible solutions, improvements, prospects, and challenges.
In addition, we discuss the limiting factors in the applications of genetically modified NHP models as well as the possible solutions and improvements. Furthermore, we highlight the prospects and challenges of the gene-edited NHP models.
Applications of genetically modified nonhuman primate models face limiting factors, and the review discusses possible solutions, improvements, prospects, and challenges.
In addition, we discuss the limiting factors in the applications of genetically modified NHP models as well as the possible solutions and improvements. Furthermore, we highlight the prospects and challenges of the gene-edited NHP models.
Applications of genetically modified nonhuman primate models face limiting factors, and the review discusses possible solutions, improvements, prospects, and challenges.
In addition, we discuss the limiting factors in the applications of genetically modified NHP models as well as the possible solutions and improvements. Furthermore, we highlight the prospects and challenges of the gene-edited NHP models.
Nonhuman primates have advantages for disease-model construction and drug development because they are closer to humans in genetic evolution, physiology, immunology, biochemistry, and pathology.
Because of the closer proximity to humans in terms of genetic evolution, physiology, immunology, biochemistry, and pathology, nonhuman primates (NHPs) have outstanding advantages in model construction for disease mechanism study and drug development.
Nonhuman primates have advantages for disease-model construction and drug development because they are closer to humans in genetic evolution, physiology, immunology, biochemistry, and pathology.
Because of the closer proximity to humans in terms of genetic evolution, physiology, immunology, biochemistry, and pathology, nonhuman primates (NHPs) have outstanding advantages in model construction for disease mechanism study and drug development.
Nonhuman primates have advantages for disease-model construction and drug development because they are closer to humans in genetic evolution, physiology, immunology, biochemistry, and pathology.
Because of the closer proximity to humans in terms of genetic evolution, physiology, immunology, biochemistry, and pathology, nonhuman primates (NHPs) have outstanding advantages in model construction for disease mechanism study and drug development.
Nonhuman primates have advantages for disease-model construction and drug development because they are closer to humans in genetic evolution, physiology, immunology, biochemistry, and pathology.
Because of the closer proximity to humans in terms of genetic evolution, physiology, immunology, biochemistry, and pathology, nonhuman primates (NHPs) have outstanding advantages in model construction for disease mechanism study and drug development.
Nonhuman primates have advantages for disease-model construction and drug development because they are closer to humans in genetic evolution, physiology, immunology, biochemistry, and pathology.
Because of the closer proximity to humans in terms of genetic evolution, physiology, immunology, biochemistry, and pathology, nonhuman primates (NHPs) have outstanding advantages in model construction for disease mechanism study and drug development.
Nonhuman primates have advantages for disease-model construction and drug development because they are closer to humans in genetic evolution, physiology, immunology, biochemistry, and pathology.
Because of the closer proximity to humans in terms of genetic evolution, physiology, immunology, biochemistry, and pathology, nonhuman primates (NHPs) have outstanding advantages in model construction for disease mechanism study and drug development.
Nonhuman primates have advantages for disease-model construction and drug development because they are closer to humans in genetic evolution, physiology, immunology, biochemistry, and pathology.
Because of the closer proximity to humans in terms of genetic evolution, physiology, immunology, biochemistry, and pathology, nonhuman primates (NHPs) have outstanding advantages in model construction for disease mechanism study and drug development.
The review mainly focuses on establishment of gene-edited rhesus and cynomolgus monkeys.
This review summarizes the current progress in the establishment of NHPs using gene editing technology, which mainly focuses on rhesus and cynomolgus monkeys.
The review mainly focuses on establishment of gene-edited rhesus and cynomolgus monkeys.
This review summarizes the current progress in the establishment of NHPs using gene editing technology, which mainly focuses on rhesus and cynomolgus monkeys.
The review mainly focuses on establishment of gene-edited rhesus and cynomolgus monkeys.
This review summarizes the current progress in the establishment of NHPs using gene editing technology, which mainly focuses on rhesus and cynomolgus monkeys.
The review mainly focuses on establishment of gene-edited rhesus and cynomolgus monkeys.
This review summarizes the current progress in the establishment of NHPs using gene editing technology, which mainly focuses on rhesus and cynomolgus monkeys.
The review mainly focuses on establishment of gene-edited rhesus and cynomolgus monkeys.
This review summarizes the current progress in the establishment of NHPs using gene editing technology, which mainly focuses on rhesus and cynomolgus monkeys.
The review mainly focuses on establishment of gene-edited rhesus and cynomolgus monkeys.
This review summarizes the current progress in the establishment of NHPs using gene editing technology, which mainly focuses on rhesus and cynomolgus monkeys.
The review mainly focuses on establishment of gene-edited rhesus and cynomolgus monkeys.
This review summarizes the current progress in the establishment of NHPs using gene editing technology, which mainly focuses on rhesus and cynomolgus monkeys.
Approval Evidence
3 sources7 linked approval claimsfirst-pass slugs gene-editing, gene-editing-technology
Advancements in gene therapy strategies, including gene augmentation, gene editing, RNA-based therapies, and optogenetics, have led to significant progress in preclinical studies and clinical trials across various PSED subtypes.
Source:
Innovative genetic therapies, such as gene editing technology and optogenetic manipulation, are emerging as promising tools for restoring E/I balance
Source:
In terms of animal model construction, gene editing technology has been widely applied to this area in recent years.
Source:
limitationsupports
Gene editing technology and optogenetic manipulation face challenges in direct application to human conditions.
Source:
progress summarysupports
Gene augmentation, gene editing, RNA-based therapies, and optogenetics have shown significant progress in preclinical studies and clinical trials across posterior segment eye disease subtypes.
Source:
therapeutic potentialsupports
Gene editing technology is an emerging promising tool for restoring excitatory/inhibitory balance and may help ameliorate motor deficits in aging.
Source:
application summarysupports
Gene editing technology has been widely applied to nonhuman primate animal model construction in recent years.
In terms of animal model construction, gene editing technology has been widely applied to this area in recent years.
Source:
challenge summarymixed
Applications of genetically modified nonhuman primate models face limiting factors, and the review discusses possible solutions, improvements, prospects, and challenges.
In addition, we discuss the limiting factors in the applications of genetically modified NHP models as well as the possible solutions and improvements. Furthermore, we highlight the prospects and challenges of the gene-edited NHP models.
Source:
review scope summarysupports
Nonhuman primates have advantages for disease-model construction and drug development because they are closer to humans in genetic evolution, physiology, immunology, biochemistry, and pathology.
Because of the closer proximity to humans in terms of genetic evolution, physiology, immunology, biochemistry, and pathology, nonhuman primates (NHPs) have outstanding advantages in model construction for disease mechanism study and drug development.
Source:
scope focusneutral
The review mainly focuses on establishment of gene-edited rhesus and cynomolgus monkeys.
This review summarizes the current progress in the establishment of NHPs using gene editing technology, which mainly focuses on rhesus and cynomolgus monkeys.
Source:
Comparisons
Source-backed strengths
The main supported strength is demonstrated adoption: gene editing technology has been widely applied to nonhuman primate animal model construction in recent years. This indicates practical relevance for generating genetically modified primate models, but the supplied evidence does not provide quantitative performance metrics.
Ranked Citations
- 1.
- 2.
- 3.